EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Insights into adherence to medication and lifestyle recommendations in an international cohort of patients with catecholaminergic polymorphic ventricular tachycardia

Puck J Peltenburg iD, Lieke M van den Heuvel iD, Dania Kallas, Cheyanne Bell iD, Isabelle Denjoy iD, Elijah R Behr iD, Ella Field, Janneke A E Kammeraad iD, Sing-Chien Yap iD, Vincent Probst iD, Michael J Ackerman iD, Nico A Blom iD und 3 weitere

Europace · 2024

DOI: 10.1093/europace/euae044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Europace, 2024. Verfasst von Puck J Peltenburg und 14 weiteren Autor:innen. Beteiligte Einrichtung: Deparment of Clinical and Exprimental Cardiology, Heart Center, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Flecainide, Tachycardia, Ventricular. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AEPC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

In patients with catecholaminergic polymorphic ventricular tachycardia (CPVT), a rare inherited arrhythmia syndrome, arrhythmic events can be prevented by medication and lifestyle recommendations. In patients who experience breakthrough arrhythmic events, non-adherence plays an essential role. We aimed to investigate the incidence and potential reasons for non-adherence to medication and lifestyle recommendations in a large, international cohort of patients with CPVT. Methods and results An online multilingual survey was shared with CPVT patients worldwide by their cardiologists, through peer-recruitment, and on social media from November 2022 until July 2023. Self-reported non-adherence was measured using the validated Medication Adherence Rating Scale (MARS) and a newly developed questionnaire about lifestyle. Additionally, validated questionnaires were used to assess potential reasons for medication non-adherence. Two-hundred-and-eighteen patients completed the survey, of whom 200 (92%) were prescribed medication [122 (61%) female; median age 33.5 years (interquartile range: 22–50)]. One-hundred-and-three (52%) were prescribed beta-blocker and flecainide, 85 (43%) beta-blocker, and 11 (6%) flecainide. Thirty-four (17%) patients experienced a syncope, aborted cardiac arrest or appropriate implantable cardioverter defibrillator shock after diagnosis. Nineteen (13.4%) patients were exercising more than recommended. Thirty (15%) patients were non-adherent to medication. Female sex [odds ratio (OR) 3.7, 95% confidence interval (CI) 1.3–12.0, P = 0.019], flecainide monotherapy compared to combination therapy (OR 6.8, 95% CI 1.6–31.0, P = 0.010), and a higher agreement with statements regarding concerns about CPVT medication (OR 1.2, 95% CI 1.1–1.3, P < 0.001) were independently associated with non-adherence.

Conclusion

The significant rate of non-adherence associated with concerns regarding CPVT-related medication, emphasizes the potential for improving therapy adherence by targeted patient education.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlecainideTachycardia, VentricularHumansFemaleAdultMaleAnti-Arrhythmia AgentsLife StyleMedication AdherenceRyanodine Receptor Calcium Release ChannelPolymorphic Catecholaminergic Ventricular Tachycardia

Stichwörter der Autor:innen

AdherenceCatecholaminergic polymorphic ventricular tachycardia

Substanzen

FlecainideAnti-Arrhythmia AgentsRyanodine Receptor Calcium Release Channel

Autor:innen und Institutionen

  • Deparment of Clinical and Exprimental Cardiology, Heart Center, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Department of Pediatric Cardiology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Department of Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Netherlands Heart Institute, Utrecht, the Netherlands.
  • Department of Pediatrics, BC Children's Hospital, University of British Columbia, Vancouver, Canada.
  • Windland Smith Rice Sudden Death Genomics Laboratory, Division of Heart Rhythm Services and Pediatric Cardiology, Departments of Cardiovascular Medicine, Pediatric and Adolescent Medicine, and Molecular Pharmacology & E…

ORCID-Profile: Puck J Peltenburg, Lieke M van den Heuvel, Cheyanne Bell, Isabelle Denjoy, Elijah R Behr, Janneke A E Kammeraad, Sing-Chien Yap, Vincent Probst, Michael J Ackerman, Nico A Blom, Arthur A M Wilde, Sally-Ann B Clur, Christian van der Werf

Förderung

  • AEPC

Zitieren

APA

Peltenburg, P. J., van den Heuvel, L. M., Kallas, D., Bell, C., Denjoy, I., Behr, E. R., Field, E., Kammeraad, J. A. E., Yap, S. C., Probst, V., Ackerman, M. J., Blom, N. A., Wilde, A. A. M., Clur, S. B., & van der Werf, C. (2024). Insights into adherence to medication and lifestyle recommendations in an international cohort of patients with catecholaminergic polymorphic ventricular tachycardia. Europace. https://doi.org/10.1093/europace/euae044

Vancouver

Peltenburg PJ, van den Heuvel LM, Kallas D, Bell C, Denjoy I, Behr ER, et al. Insights into adherence to medication and lifestyle recommendations in an international cohort of patients with catecholaminergic polymorphic ventricular tachycardia. Europace. 2024. doi:10.1093/europace/euae044

BibTeX
@article{Peltenburg2024,
  author = {Peltenburg, Puck J and van den Heuvel, Lieke M and Kallas, Dania and Bell, Cheyanne and Denjoy, Isabelle and Behr, Elijah R and Field, Ella and Kammeraad, Janneke A E and Yap, Sing-Chien and Probst, Vincent and Ackerman, Michael J and Blom, Nico A and Wilde, Arthur A M and Clur, Sally-Ann B and van der Werf, Christian},
  title = {Insights into adherence to medication and lifestyle recommendations in an international cohort of patients with catecholaminergic polymorphic ventricular tachycardia},
  journal = {Europace},
  year = {2024},
  doi = {10.1093/europace/euae044}
}
Kostenlos starten →